These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 5371198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF, Calhoun DW.
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K, Mishra JS, Swarnkar G, Siddiqui JA, Khan K, Kumari R, Rawat P, Maurya R, Sanyal S, Chattopadhyay N.
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [Abstract] [Full Text] [Related]

  • 6. Future therapeutic targets in osteoporosis.
    Deal C.
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [Abstract] [Full Text] [Related]

  • 7. Uterine alkaline and acid phosphatase activity in the rhesus monkey treated with synthetic estrogen.
    Manning JP, Tornaben JA, Schwartz E.
    Am J Obstet Gynecol; 1969 Oct 01; 105(3):412-7. PubMed ID: 4980377
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nitrogen-retaining steroids and their application in disease.
    Querido A, Kassenaar AA.
    Adv Metab Disord; 1965 Oct 01; 2():79-113. PubMed ID: 4924372
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Steroidal imidazole-1-carboxylic acid esters.
    Fahrenholtz KE, Boris A, Kennedy TW, Kierstead RW.
    J Med Chem; 1974 Mar 01; 17(3):337-42. PubMed ID: 4811231
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].
    Krüskemper HL, Morgner KD, Noell G.
    Arzneimittelforschung; 1967 Apr 01; 17(4):449-54. PubMed ID: 5632439
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between catabolic and anabolic steroids.
    Little K.
    Curr Ther Res Clin Exp; 1970 Oct 01; 12(10):658-76. PubMed ID: 4991099
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of the percentage of increased spongy bone in experimental osteoporosis treated with synthetic anabolic agents].
    Carrozzo M, Pallante R, Lo Sasso F, D'Amore M.
    Rev Rhum Mal Osteoartic; 1983 Jun 01; 50(7):501-5. PubMed ID: 6612200
    [Abstract] [Full Text] [Related]

  • 20. Clinical management of osteoporosis.
    Mulloy AL, Weinstein RS.
    J Med Assoc Ga; 1994 Apr 01; 83(4):227-30. PubMed ID: 8006552
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.